Phase 3 trial of Ebola vaccine to begin within weeks in Congo

Plans are underway to launch a phase 3 trial of an existing Ebola vaccine to fight the ongoing deadly outbreak in the Democratic Republic of the Congo, WHO told Healio.The trial could begin by mid-September, a much faster timeline than the 5 to 12 months typically needed for clinical trials being conducted outside an outbreak zone, WHO noted.